Literature DB >> 17577925

Expression analysis of nuclear factor of activated T cells (NFAT) during myeloid differentiation of CD34+ cells: regulation of Fas ligand gene expression in megakaryocytes.

Alexander Kiani1, Hanna Kuithan, Friederike Kuithan, Satu Kyttälä, Ivonne Habermann, Achim Temme, Martin Bornhäuser, Gerhard Ehninger.   

Abstract

OBJECTIVE: Nuclear factor of activated T cells (NFAT) transcription factors belong to a family of five proteins that are primarily known for their central role in the regulation of inducible gene expression in activated T cells. Little information exists on the expression or function of NFAT family members in hematopoietic cells, during myeloid differentiation or in myeloid cells.
MATERIALS AND METHODS: In the present study, we establish a comprehensive expression profile of all five NFAT family members in human CD34+ hematopoietic progenitor cells and during their ex vivo differentiation into neutrophil, eosinophil, erythroid, and megakaryocytic lineages. Based on the observed expression pattern, the role of NFAT in Fas ligand gene expression in megakaryocytes was investigated.
RESULTS: When CD34+ cells are induced to differentiate into neutrophil granulocytes, expression of all NFAT family members is rapidly suppressed. In contrast, regulation of NFAT expression during eosinophil, erythroid, and megakaryocytic differentiation follows a family member- and lineage-specific pattern. Most obviously, transcript and protein levels of NFATc4 are specifically upregulated about 10-fold during megakaryocytic differentiation, while they remain almost undetectable in neutrophil, eosinophil, and erythroid cells. As a first evidence for a functional role for NFAT in this cell type, NFAT was found to be strictly required for both the constitutive and inducible expression of the Fas ligand gene in megakaryocytes.
CONCLUSION: The expression pattern of NFAT and its family member- and lineage-specific regulation during myeloid differentiation will prompt further studies on the role of NFAT in myeloid cells, particularly in megakaryocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17577925     DOI: 10.1016/j.exphem.2007.02.001

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  15 in total

Review 1.  NFAT, immunity and cancer: a transcription factor comes of age.

Authors:  Martin R Müller; Anjana Rao
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

2.  Requirement for balanced Ca/NFAT signaling in hematopoietic and embryonic development.

Authors:  Martin R Müller; Yoshiteru Sasaki; Irena Stevanovic; Edward D Lamperti; Srimoyee Ghosh; Sonia Sharma; Curtis Gelinas; Derrick J Rossi; Matthew E Pipkin; Klaus Rajewsky; Patrick G Hogan; Anjana Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-07       Impact factor: 11.205

3.  Osteomyelosclerosis, anemia and extramedullary hematopoiesis in mice lacking the transcription factor NFATc2.

Authors:  Wolfgang Bauer; Martina Rauner; Michael Haase; Satu Kujawski; Laleh S Arabanian; Ivonne Habermann; Lorenz C Hofbauer; Gerhard Ehninger; Alexander Kiani
Journal:  Haematologica       Date:  2011-07-12       Impact factor: 9.941

4.  Real-time deformability cytometry: on-the-fly cell mechanical phenotyping.

Authors:  Oliver Otto; Philipp Rosendahl; Alexander Mietke; Stefan Golfier; Christoph Herold; Daniel Klaue; Salvatore Girardo; Stefano Pagliara; Andrew Ekpenyong; Angela Jacobi; Manja Wobus; Nicole Töpfner; Ulrich F Keyser; Jörg Mansfeld; Elisabeth Fischer-Friedrich; Jochen Guck
Journal:  Nat Methods       Date:  2015-02-02       Impact factor: 28.547

5.  NFATc1 as a therapeutic target in FLT3-ITD-positive AML.

Authors:  S K Metzelder; C Michel; M von Bonin; M Rehberger; E Hessmann; S Inselmann; M Solovey; Y Wang; K Sohlbach; C Brendel; T Stiewe; J Charles; A Ten Haaf; V Ellenrieder; A Neubauer; S Gattenlöhner; M Bornhäuser; A Burchert
Journal:  Leukemia       Date:  2015-04-14       Impact factor: 11.528

6.  Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome.

Authors:  Sébastien Malinge; Meghan Bliss-Moreau; Gina Kirsammer; Lauren Diebold; Timothy Chlon; Sandeep Gurbuxani; John D Crispino
Journal:  J Clin Invest       Date:  2012-02-22       Impact factor: 14.808

7.  The calcineurin-NFAT pathway negatively regulates megakaryopoiesis.

Authors:  Alexander Zaslavsky; Stella T Chou; Keri Schadler; Allyson Lieberman; Maxim Pimkin; Yeo Jung Kim; Kwan-Hyuck Baek; William C Aird; Mitchell J Weiss; Sandra Ryeom
Journal:  Blood       Date:  2013-02-27       Impact factor: 22.113

8.  Early growth response-1 (EGR-1) and nuclear factor of activated T cells (NFAT) cooperate to mediate CD40L expression in megakaryocytes and platelets.

Authors:  Scott A Crist; Bennett D Elzey; Michelle T Ahmann; Timothy L Ratliff
Journal:  J Biol Chem       Date:  2013-10-08       Impact factor: 5.157

9.  Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes.

Authors:  Scott A Crist; Daniel L Sprague; Timothy L Ratliff
Journal:  Blood       Date:  2008-01-07       Impact factor: 22.113

10.  Calcineurin/NFAT signalling inhibits myeloid haematopoiesis.

Authors:  Jan Fric; Clarice X F Lim; Esther G L Koh; Benjamin Hofmann; Jinmiao Chen; Hock Soon Tay; Siti Aminah Bte Mohammad Isa; Alessandra Mortellaro; Christiane Ruedl; Paola Ricciardi-Castagnoli
Journal:  EMBO Mol Med       Date:  2012-02-07       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.